Diabetes
Conditions
Keywords
insulin practice, Dependent patient, Smart connected insulin pen
Brief summary
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?
Detailed description
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. Current practice and my experience in diabetes show a misuse of insulin therapy by caregivers at home and in institutions. Studies on the elderly insulin-treated person living in institutions show, through continuous glucose measurement, frequent nocturnal hypoglycemia at 79%. The continuous measurement of glucose has also shown its interest in reducing hospitalizations for acute event and, permanently. A norwegian study shows that hypoglycemic treatments are too frequently prescribed in nursing homes. Hospitalizations for severe hypoglycemia are often due to dose errors or unsupervised recommendations in people over 65 years. Smart connected insulin pens have shown a benefit in the management of insulin therapy in patients living with type 1 diabetes, improving glycemic balance. Study focuses on the identification of misuses of insulin therapy in dependent and/or institutionalized patients. A study of everyday life, we expect a decrease in dysfunctions in patients equipped with a continuous glucose measurement system and connected pens after advice given to their caregivers.
Interventions
BEHAVIORALCounseling home caregivers
Advice on the proper use of insulin therapy will be given, if necessary, to caregivers. Patients are reviewed at 1 month of this first visit with a collection of the same data
Sponsors
Centre Hospitalier Sud Francilien
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Older than 18 years patient with type 1 or 2 diabetes * Treated with multiple insulin injections * Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before * Dependent on a health professional for treatment management. * Subject informed of the study and not objecting to data collection.
Exclusion criteria
\- Patient refusing study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Insulin Injection | at day 0 | Percentage of insulin injections not as prescribed |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| number of missed injections | at day 0 | Percentage of missed injections |
| number of injections | at day 0 | Percentage of injections performed with a dose deviation of +-20% from the prescribed dose |
| Continuous glucose measurement parameters | at day 0 | Time in range |
| Acute Diabetes Events | at day 0 | severe hypoglycemia, hyperglycemia requiring hospitalization |
Countries
France
Contacts
Primary ContactMarie BOULY, APN
Backup ContactCaroline TOURTE
Outcome results
None listed